Anju Menon
- Molecular Medicine top 1%
- Pharmacology top 5%
- Applied Microbiology and Biotechnology top 1%
- Epidemiology
- Critical Care and Intensive Care Medicine top 10%
- Co-authors
- Yuko MatsunagaRoger EcholsRichard G. WunderinkMari AriyasuTsutae Den NagataMarin H. KollefJason M. PogueJean‐François Timsit
- Topics
- Antibiotics Pharmacokinetics and Efficacy (3 papers)Pneumonia and Respiratory Infections (3 papers)Antibiotic Resistance in Bacteria (2 papers)
- Journals
- The Lancet Infectious DiseasesJournal of Antimicrobial ChemotherapyEuropean Journal of Clinical Microbiology & Infectious Diseases
- Partner nations
- United StatesJapanFrance
In The Last Decade
Anju Menon
5 papers receiving 374 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Molecular Medicine 313
- Pharmacology 249
- Applied Microbiology and Biotechnology 150
- Epidemiology 121
- Critical Care and Intensive Care Medicine 55
Countries citing papers authored by Anju Menon
This map shows the geographic impact of Anju Menon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anju Menon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anju Menon more than expected).
Fields of papers citing papers by Anju Menon
This network shows the impact of papers produced by Anju Menon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anju Menon. The network helps show where Anju Menon may publish in the future.
Co-authorship network of co-authors of Anju Menon
This figure shows the co-authorship network connecting the top 25 collaborators of Anju Menon. A scholar is included among the top collaborators of Anju Menon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anju Menon. Anju Menon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 42 | |
| 3 | Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trialbreakdown → | 319 |
| 4 | 1 | |
| 5 | 13 |
About Anju Menon
Anju Menon is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 5 papers that have together received 380 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Pneumonia and Respiratory Infections (3 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (150 citations), Molecular Medicine (313 citations) and Pharmacology (249 citations). Anju Menon has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Yuko Matsunaga, Roger Echols, Richard G. Wunderink, Mari Ariyasu, Tsutae Den Nagata, Marin H. Kollef, Jason M. Pogue, Jean‐François Timsit, Philippe Clevenbergh and Markus Zeitlinger. Their work appears in journals such as The Lancet Infectious Diseases, Journal of Antimicrobial Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.